logo-loader
Medlab Clinical Ltd

Medlab Clinical chief updates on progress with NanaBis and NRG Biotic

Medlab Clinical Ltd (ASX:MDC) managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference & Trade Exhibition (APP2019).

Hall updates on the progress of clinical trials for NRGBiotic™, a nutraceutical already available in pharmacies.

He also discusses a recent heads of agreement (HoA) reached with Canadian pharmaceutical company Pharmascience Inc. for the further development and global distribution of NanaBis™, which is also progressing through clinical trials.

Quick facts: Medlab Clinical Ltd

Price: $0.46

Market: ASX
Market Cap: $99.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Medlab Clinical Ltd named herein, including the promotion by the Company of Medlab Clinical Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.   Hall says there has been a shortfall in the standard of...

on 05/07/2019

RNS

Result of AGM

on 07/25/2019

Directorate Change

on 07/24/2019

Directorate Change

on 07/24/2019

Holding(s) in Company

on 07/01/2019

Holding(s) in Company

on 07/01/2019

Annual Financial Report

on 06/21/2019

2 min read